Valganciclovir: once-daily alternative to ganciclovir for CMV

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1365, 2002-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of Valganciclovir and Ganciclovir Following Multiple Oral Dosages of Valganciclovir in HIV- and CMV-Seropositive Volunteers

By Brown F.  

Clinical Pharmacokinetics, Vol. 37, Iss. 2, 1999-08 ,pp. : 167-176

Adis International

Access to resources Recommend Favorite

Exposure to ganciclovir with oral valganciclovir exceeds that of oral ganciclovir

By  

Inpharma, Vol. 1, Iss. 1487, 2005-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Once-daily tobramycin the TOPIC of the day

By  

Inpharma, Vol. 1, Iss. 1475, 2005-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Targeted CMV prophylaxis with valganciclovir viable

By  

Inpharma, Vol. 1, Iss. 1289, 2001-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Targeted CMV prophylaxis with valganciclovir viable

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 314, 2001-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite